Intensifying Daunorubicin in Induction for Patients with Core Binding Factor Leukemia
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-12-15
著者
-
Yamaguchi Yuko
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
SAITO Takeshi
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
USUI Noriko
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
ASAI Osamu
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
DOBASHI Nobuaki
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
YANO Shingo
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
OSAWA Hiroshi
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
TAKEI Yutaka
Division of Oncology and Hematology, Department of Internal Medicine, Jikei University School of Med
-
YAHAGI Yuichi
Division of Hematology and Oncology, Department of Internal Medicine, Jikei University School of Med
-
SUGIYAMA Katsuki
Division of Hematology and Oncology, Department of Internal Medicine, Jikei University School of Med
-
Shimoda Kazuya
九州大学 医学部病態情報学
-
Shimoda Kazuya
九州大学 第1内科
-
Usubuchi Noriko
国立がんセンター中央病院
-
Usubuchi Noriko
Hematology And Oncology Division National Cancer Center Hospital East
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center Hospital
-
Uike N
National Kyusyu Cancer Center
-
Uoshima Nobuhiko
京都府立医科大学 血液･腫瘍内科学
-
Uoshima Nobuhiko
Matsushita Memorial Hospital Moriguchi Jpn
-
Uoshima Nobuhiko
1st Department Of Internal Medicine Kyoto Prefectureal University Of Medicine
-
Usui Noriko
東京慈恵会医科大学附属病院 中央検査部
-
Usui N
Division Of Hematology And Oncology Department Of Medicine Jikei University
-
Usui Noriko
Jikei University Hospital
-
DOBASHI Nobuaki
Jikei University Hospital
-
Dobashi Nobuaki
東京慈恵会医科大学 内科学(血液･腫瘍)
-
Dobashi Nobuaki
Department Of Clinical Oncology And Hematology School Of Medicine The Jikei University
-
Dobashi Nobuaki
Division Of Hematology And Oncology Department Of Internal Medicine Jikei University School Of Medic
-
Shinagawa K
Okayama Univ. Hospital Okayama Jpn
-
Shinagawa Katsuji
岡山大学 第2内科
-
Usui N
Jikei University Hospital
-
Shinjo Kaori
浜松医科大学 内科学第3
-
Uike Naokuni
Department Of Hemato-oncology Kyushu Cancer Center
-
Asai Osamu
Department Of Clinical Oncology And Hematology School Of Medicine The Jikei University
-
Takei Yutaka
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Yahagi Yuichi
Division Of Hematology And Oncology Department Of Internal Medicine Jikei University School Of Medic
-
Otsubo Hiroko
Division Of Hematology And Oncology Department Of Medicine Jikei University
-
Otsubo Hiroko
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Shimada Takaki
Divesion Of Hematology And Oncology Department Of Internal Medicine Jikei University School Of Medic
-
Shimoda Kazuya
Department Of Internal Medicine Gastroenterology And Hematology Faculty Of Medicine Miyazaki Univers
-
Osawa Hiroshi
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Usui Noriko
Jikei Univ. Hospital Tokyo Jpn
-
Usui Noriko
The "lung Injury By Bortezomib" Joint Committee Of The Japanese Society Of Hematology And
-
Shigeno Kazuyuki
Japan Adult Leukemia Study Group Hamamatsu Jpn
-
Sunami K
Department Of Hematology National Hospital Organization Okayama Medical Center
-
Shinagawa Katsushi
The Second Department Of Internal Medicine
-
Shinagawa Katsuji
Department Of Biopathological Science Okayama University Graduate School Of Medicine And Dentistry
-
Shinagawa Katsuji
Division Of Hematology/oncology Okayama University Medical School
-
Asai Osamu
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Dobashi Nobuaki
Jikei Univ. Hospital Tokyo Jpn
-
Sugiyama Katsuki
Division Of Hematology And Oncology Department Of Internal Medicine Jikei University School Of Medic
-
Sugiyama Katsuki
Department Of Medical Oncology Cancer Institute Hospital And Cancer Chemotherapy Center Japanese Fou
-
Sekita Toru
Department Of Internal Medicine (ii) Jikei University School Of Medicine
-
Yano Shingo
Division Of Oncology And Hematology Department Of Internal Medicine Jikei University School Of Medic
-
Usui Noriko
Division Of Oncology & Hematology Department Of Internal Medicine The Jikei University School Of
-
Usui Noriko
Division Of Hematology And Oncology Department Of Internal Medicine Jikei University School Of Medic
-
Osawa Hiroshi
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Yano Shingo
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Sugiyama Katsuki
Division Of Hematology And Oncology Department Of Internal Medicine The Jikei University School Of M
-
Asai Osamu
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Yamaguchi Yuko
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Takei Yutaka
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Saito Takeshi
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Sugiyama Katsuki
Division Of Clinical Oncology And Hematology Department Of Internal Medicine Jikei University School
-
Osawa Hiroshi
Division Of Cardiovascular Surgery Shimada General Hospital
-
DOBASHI Nobuaki
Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine
-
SAITO Takeshi
Division of Cardiovascular Surgery, Tohoku University Graduate School of Medicine
関連論文
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Functional involvement of Daxx in gp130-mediated cell growth and survival in BaF3 cells
- Elevated serum levels of human matrix metalloproteinase-9 (MMP-9) during the induction of peripheral blood stem cell mobilization by granulocyte colony-stimulating factor (G-CSF)
- Intensifying Daunorubicin in Induction for Patients with Core Binding Factor Leukemia
- Intensified Daunorubicin in Induction Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Postremission Therapy (Double-7 Protocol) for Adult Acute Myeloid Leukemia
- Severe Aplastic Anemia Associated With Chronic Natural Killer Cell Lymphocytosis
- Cardiac Lesions Leading to Sudden Death in a Beagle
- Reconstitution of HLA-A^*2402-Restricted Cytomegalovirus-Specific T-Cells following Stem Cell Transplantation
- Chronic Graft-versus-Host Disease following Varicella-Zoster Virus Infection in Allogeneic Stem Cell Transplant Recipients
- G-CSF does not Stimulate Leukemic Stem Cells in Vivo
- Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura With an IgG-Type Inhibitor to von Willebrand Factor-Cleaving Protease Activity
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies
- Allogeneic Peripheral Blood Stem Cell Transplantation in 23 Adult Patients With Hematologic Malignancies: A Single-Center Experience
- Granulocyte Colony-Stimulating Factor and Lineage-Independent Modulation of VLA-4 Expression on Circulating CD34^+ Cells
- Replating potential of colony-forming units of granulocytes/macrophages (CFE-GM) expanded ex vivo by stem cell factor, interleukin (IL)-3, IL-6, granulocyte colony-stimulating factor, erythropoietin with or without thrombopoietin
- G-CSF-induced mobilization of peripheral blood stem cells for allografting: comparative study of daily single versus divided dose of G-CSF
- Predominant Infiltration of Monocytes in Chronic Graft-Versus-Host Disease
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Early cytomegalovirus (CMV) gastrointestinal disease that developed 19 days after bone marrow transplantation, with a high-level of CMV antigenemia, of up to 1120 cells/slide
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Phase II Study of Cladribine(2-Chlorodeoxyadenosine) in Relapsed or Refractory Adult T-Cell Leukemia-Lymphoma
- The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma : a propensity score matching analysis
- Two Cases of Acute Promyelocytic Leukemia Complicated by Torsade de Pointes during Arsenic Trioxide Therapy
- Two Patients with All-trans Retinoic Acid-Resistant Acute Promyelocytic Leukemia Treated Successfully with Gemtuzumab Ozogamicin as a Single Agent
- Glanzmann Thrombasthenia with Acute Myeloid Leukemia Successfully Treated by Bone Marrow Transplantation
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Expression of Human Tumor-Associated Antigen RCAS1 in Adult T-Cell Leukemia/Lymphoma
- Successful Engraftment of Allogeneic Peripheral Blood Stem Cell Transplant After Nonmyeloablative Preparative Regimen With Cytarabine and Cyclophosphamide: Report of 2 Cases
- Molecular characterization of total kininogen deficiency in Japanese patients
- Analysis of circulating hematopoietic progenitor cells after peripheral blood stem cell transplantation
- Risk of Neutropenic Fever and Early Infectious Complications after Autologous Peripheral Blood Stem Cell Transplantation for Malignant Diseases
- Successful Treatment of Progressive NK Cell Lymphoma with Allogeneic Peripheral Stem Cell Transplantation Followed by Early Cyclosporine Tapering and Donor Leukocyte Infusions
- Ocular Manifestation of Acute Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation
- Severe Bleeding Tendency Caused by Leukemic Infiltration and Destruction of Vascular Walls in Chronic Neutrophilic Leukemia
- Transient Factor VIII Inhibitor in a Hemophilia Patient After Staphylococcal Septic Shock Syndrome
- Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
- Successful treatment of cryoglobulinemic glomerulonephritis derived from Waldenstrom's macroglobulinemia by rituximab-CHOP and tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation
- Phase I/II study of tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation for advanced multiple myeloma
- Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation
- Calcineurin Inhibitor-Induced Irreversible Neuropathic Pain after Allogeneic Hematopoietic Stem Cell Transplantation
- Myositis as a Manifestation of Chronic Graft-Versus-Host Disease
- Allogeneic Peripheral Blood Stem Cell Transplantation for the Treatment of Refractory Follicular Lymphoma
- Treatment of Refractory Metastatic Choriocarcinoma with Tandem High-Dose Chemotherapy Supported by Peripheral Blood Stem Cell Transplantation : A Case Report
- Graft rejection and recovery of host-derived hematopoiesis after allogeneic bone marrow transplantation : relation to conditioning with high does etoposide and total body irradiation
- Physical and functional interactions between ZIP kinase and UbcH5
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- Oncogene Associated cDNA Microarray Analysis Shows PRAME Gene Expression is a Marker for Response to Anthracycline Containing Chemotherapy in Patients with Diffuse Large B-cell Lymphoma
- Pulmonary infiltration with eosinophilia syndrome complicated with non-Hodgkin's lymphoma of B cell lineage
- Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia
- Metastasis to the Iris in Squamous Cell Lung Cancer
- High-Dose Etoposide Treatment for CNS Involvement in a Patient with Primary Non-Hodgkin's Lymphoma of the Breast
- An RNA biding protein, Y14 interacts with and modulates STAT3 activation
- The exon-junction complex proteins, Y14 and MAGOH regulate STAT3 activation
- Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor Regulates Enhanced Activation of Signal Transducer and Activator of Transcription 3 by Epstein-Barr Virus-Derived Epstein-Barr Nuclear Antigen 2
- STAP-2 Negatively Regulates both Canonical and Noncanonical NF-κB Activation Induced by Epstein-Barr Virus-Derived Latent Membrane Protein 1
- The IL-6 family of cytokines modulates STAT3 activation by desumoylation of PML through SENP1 induction
- Sumoylation of Smad3 stimulates its nuclear export during PIASy-mediated suppression of TGF-β signaling
- KAP1 regulates type I interferon/STAT1-mediated IRF-1 gene expression
- LIF- and IL-6-Induced Acetylation of STAT3 at Lys-685 through PI3K/Akt Activation.
- DUSP22/LMW-DSP2 regulates estrogen receptor-α-mediated signaling through dephosphorylation of Ser-118
- Phosphorylation of threonine-265 in Zipper-interacting protein kinase plays an important role in its activity and is induced by IL-6 family cytokines
- HDAC3 influences phosphorylation of STAT3 at serine 727 by interacting with PP2A
- Epstein-Barr virus-derived EBNA2 regulates STAT3 activation
- The role of Tyk2, Stat1 and Stat4 in LPS-induced endotoxin signals
- MLL Gene Rearrangement in t(9;11) Acute Myelogenous Leukemia With Minimal Myeloid Differentiation (FAB Subtype M0)
- Successful Combination Therapy with Trastuzumab and Paclitaxel for Adriamycin- and Docetaxel-Resistant Inflammatory Breast Cancer
- Hapten-induced contact hypersensitivity is enhanced in Tyk2-deficient mice
- Physical and functional interactions between Daxx and TSG101.
- A Novel Mutation in the Juxtamembrane Intracellular Sequence of the Granulocyte Colony-Stimulating Factor (G-CSF) Receptor Gene in a Patient with Severe Congenital Neutropenia Augments G-CSF Proliferation Activity but Not through the MAP Kinase Cascade
- In Vitro Study of Deoxymethylspergualin on Functions of Lymphocytes and Bone Marrow Cells From Healthy Volunteers
- Physical and functional interactions between STAP-2/BKS and STAT5.
- Daxx enhances Fas-mediated apoptosis in a murine pro-B cell line, BAF3.
- Carcinoembryonic Antigen-Producing Multiple Myeloma Detected by a Transcription-Reverse Transcription Concerted Reaction System
- Toxicity and Outcome of Intensive Chemotherapy for Acute Lymphoblastic Leukemia Complicated with Turner's Syndrome
- CD2^+ Tetraploid Acute Promyelocytic Leukemia Variant with Double (15 ; 17) Translocations
- Septic Intramuscular Embolism in a Neutropenic Patient with Myelodysplastic Syndrome Accompanied by Asymptomatic Septic Pulmonary Emboli
- Th1/Th2 Lymphocyte Balance in Patients with Aplastic Anemia
- Physical and functional interactions between STAT3 and ZIP kinase.
- Zipper-interacting protein kinase modulates canonical Wnt/beta-catenin signaling through interacting with Nemo-like kinase and T-cell factor 4
- Roles for lysine residues of the MH2 domain of Smad3 in transforming growth factor-β signaling.
- Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Leukemia inhibitory factor-induced phosphorylation of STAP-2 on tyrosine-250 is involved in its STAT3-enhancing activity.
- Nuclear retention of STAT3 through the coiled-coil domain regulates its activity.
- Regulation of transforming growth factor-β signaling by protein inhibitor of activated STAT, PIASy through Smad3.
- The RING domain of PIASy is involved in the suppression of bone morphogenetic protein-signaling pathway.
- Involvement of NF-kB in TGF-β-mediated suppression of IL-4 signaling.
- Systemic Vasculitis Associated with α1-antitrypsin Deficiency
- Two Cases of Mediastinal Gray Zone Lymphoma
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies : analysis of eight patients
- Functional involvement of Daxx in gp130-medicated cell growth and survival in BaF3 cells
- Clinical Features and Outcomes of 35 Disseminated Intravascular Coagulation Cases Treated with Recombinant Human Soluble Thrombomodulin at a Single Institution